Please login to the form below

Not currently logged in
Email:
Password:

UCB appoints new managing director of Britain and Ireland

Steve Turley joins from Lundbeck
UCB

UCB have appointed Steve Turley as managing director for the British and Irish isles.

Turley will also be an important figure in UCB's European Leadership Team and will report to Khoso Baluch, head of EMEA Operations.

Turley joins from Lundbeck and brings with him over 20 years of experience in the pharmaceutical industry at Merck Sharp & Dohme, Roche and Actelion. He has worked across a range of therapy areas at both local and international levels.

He said: “I am pleased to be joining a dynamic business that is focused on delivering medicines that really deliver for patients.

“I am looking forward to building on that with our team here in BII.”

24th November 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics